ライフサイエンスコーパス: idiopathic

1 infections but may also be of unknown cause (idiopathic).

2 fants (59%) with NHS, of which 32 (67%) were idiopathic, 30 (35%) were hemorrhagic transformation of

3 milial Alzheimer's disease (AD) or sporadic (idiopathic) AD (sAD).

4 mate that CSF1R mutations account for 10% of idiopathic adult onset leukodystrophies and that genetic

5 Clinical features of idiopathic AEPVM and differential diagnosis.

6 Consecutive patients diagnosed with idiopathic AEPVM.

7 a-Gal-associated meat allergy (MA) patients, idiopathic anaphylaxis (IA) patients with suspected MA,

8 ty participants referred with a diagnosis of idiopathic anaphylaxis (IA), six (9%) were found to have

9 t cell disorders also occur in patients with idiopathic anaphylaxis (IA).

10 ith CSU together with those of patients with idiopathic anaphylaxis and healthy control subjects (7 o

11 le and Southern Europe cities, some cases of idiopathic anaphylaxis could potentially be caused by A.

12 ations may present as Hymenoptera-induced or idiopathic anaphylaxis.

13 dysfunction is present in patients with both idiopathic and acquired epilepsy.

14 s seen predominantly in participants who had idiopathic and cryptogenic CSE (seven [36.8%, 95% CI 19.

15 enic pathways in human neurons obtained from idiopathic and familial cases, and suggest novel targets

16 aminergic neurons derived from patients with idiopathic and familial PD.

17 Amyotrophic lateral sclerosis (ALS) is an idiopathic and fatal neurodegenerative disease of the hu

18 cing was performed on DNA from patients with idiopathic and heritable PAH and with pulmonary veno-occ

19 in patients classified clinically as having idiopathic and heritable PAH.

20 derived endothelial cells from patients with idiopathic and heritable pulmonary arterial hypertension

21 Idiopathic and heritable pulmonary arterial hypertension

22 Idiopathic and nystagmus associated with retinal/optic n

23 Idiopathic aplastic anemia (AA) is an immune-mediated an

24 itis optica spectrum disorder (NMOSD, n=10), idiopathic AQP4-IgG-negative myelitis (n=4), idiopathic

25 idiopathic AQP4-IgG-negative myelitis (n=4), idiopathic AQP4-IgG-negative optic neuritis (n=4), other

26 in the clinical management of patients with idiopathic ARP.

27 f patients, whose condition is classified as idiopathic ARP.

28 Juvenile idiopathic arthritis (JIA) is a wide group of diseases,

29 Juvenile Idiopathic Arthritis (JIA) is one of the most common chr

30 rk, a novel biosensor for detecting juvenile idiopathic arthritis (JIA) was developed based on the im

31 dren with the polyarticular form of juvenile idiopathic arthritis (JIA), using 2 independent cohorts

32 etween cow's milk allergy (CMA) and juvenile idiopathic arthritis (JIA).

33 y, is effective in the treatment of juvenile idiopathic arthritis (JIA).

34 ant in the synovia of patients with juvenile idiopathic arthritis (JIA).

35 When applied to systemic juvenile idiopathic arthritis (sJIA), an autoinflammatory disease

36 ode, aiming at the diagnosis of the juvenile idiopathic arthritis in real serum samples.

37 d course of ocular hypotony (OH) in juvenile idiopathic arthritis-associated uveitis (JIAU).

38 Many cases of juvenile idiopathic arthritis-associated uveitis, many cases of i

39 gical heterogeneity, >/=68% of syndromic and idiopathic ASD cases shared a common acetylome signature

40 of asthmatic patients have "nonallergic" or idiopathic asthma, which often takes a severe course and

41 d and analyzed genome sequence data from 516 idiopathic autism families (2,064 individuals).

42 use in RS, and, more broadly, for utility in idiopathic autism.

43 Mooren ulcer has been considered as an idiopathic autoimmune keratitis.

44 dverse outcomes in patients with ischemic or idiopathic cardiomyopathies.

45 in the outcomes of patients with ischemic or idiopathic cardiomyopathies.

46 sment score of more than 11 (3.3 [1.3-8.3]), idiopathic cardiomyopathy (0.4 [0.2-1]), cardiac disease

47 ial enrolled patients with persistent AF and idiopathic cardiomyopathy (left ventricular ejection fra

48 ve role of antibody-mediated autoimmunity in idiopathic cases of organ fibrosis, such as idiopathic p

49 xtraesophageal manifestations of reflux from idiopathic chronic cough, laryngitis due to other causes

50 Idiopathic chronic diarrhea (ICD) in rhesus macaques als

51 mobility type (JHS/EDS-HT), characterized by idiopathic chronic itch with predominantly proximal dist

52 ioedema, 13 patients (3.9%) had a history of idiopathic chronic urticaria.

53 te macular neuroretinopathy (AMN) is a rare, idiopathic condition resembling other acute maculopathie

54 he search for the cause of similar currently idiopathic conditions.

55 An algorithm provided to evaluate chronic idiopathic constipation (CIC) that is refractory to avai

56 ve mechanism of PA101, patients with chronic idiopathic cough (CIC) were also studied.

57 nts are referred to as unexplained anemia or idiopathic cytopenia of unknown significance.

58 ustered around the anatomic subtypes of IOI: idiopathic dacryoadenitis and idiopathic orbital fat inf

59 Most children in both cohorts had idiopathic DCM (64% vs. 63%, respectively).

60 nic) who meet rigorous clinical criteria for idiopathic DCM along with 2600 of their relatives.

61 escribe the prevalence of familial DCM among idiopathic DCM cases and the genetic architecture of idi

62 cipate that this study will demonstrate that idiopathic DCM has a genetic basis and guide best practi

63 ic DCM cases and the genetic architecture of idiopathic DCM in multiple ethnicity-ancestry groups.

64 ymptomatic disease, and all individuals with idiopathic DCM will undergo exome sequencing to identify

65 lamin A/C, the cause of approximately 6% of idiopathic DCM, commonly underpins more aggressive manag

66 We hypothesize that most idiopathic DCM, whether familial or nonfamilial, has a g

67 B viruses are detected in about one-third of idiopathic dilated cardiomyopathies.

68 The cause of idiopathic dilated cardiomyopathy (DCM) is unknown by de

69 rdiomyopathy (FDCM) to that of children with idiopathic dilated cardiomyopathy (IDCM) has produced co

70 thyroid function and myocardial injuries in idiopathic dilated cardiomyopathy (IDCM) using cardiac m

71 age 42+/-15.5 years; 64 patients (65.9%) had idiopathic dilated cardiomyopathy and 21 patients (21.6%

72 137 children with myocarditis and 1249 with idiopathic dilated cardiomyopathy received HT.

73 were isolated from a patient suffering from idiopathic dilated cardiomyopathy, suggesting that such

74 ing ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy.

75 in 224 eyes (40.7%) and was associated with idiopathic disease (P = 0.001) and diabetes (P = 0.001).

76 ura disease is an uncommon, benign, chronic, idiopathic disease that is seen mainly in the Asian popu

77 We evaluated incident patients with idiopathic, drug- and toxin-induced, or heritable PAH en

78 designed to evaluate how many patients with idiopathic dry eye and no evidence of systemic diseases

79 SP1, CA6 and PSP occur in some patients with idiopathic dry eyes.

80 and intraoperative data of 45 children with idiopathic EHPVT.

81 encing uncovered a novel molecular basis for idiopathic end-stage heart failure in two sisters who un

82 LVOT VAs were midrange between those of the idiopathic endocardial and epicardial LVOT VAs, and more

83 l LVOT VAs, and more similar to those of the idiopathic endocardial LVOT VAs than those of the idiopa

84 athic endocardial LVOT VAs than those of the idiopathic epicardial LVOT VAs.

85 l alterations of the central bouquet (CB) in idiopathic epiretinal membranes (ERMs).

86 s of 234 consecutive patients diagnosed with idiopathic epiretinal membranes were reviewed and analyz

87 in the inner nuclear layer in patients with idiopathic epiretinal membranes, with and without glauco

88 y-nine eyes of 29 patients with symptomatic, idiopathic ERM were included.

89 y mediators in the vitreous of patients with idiopathic ERMs.

90 ohol, steroids, following trauma or unclear (idiopathic) etiology, affecting mostly the middle aged p

91 bgroups of patients (those with a history of idiopathic falls, those with mild cognitive impairment,

92 Of 382 children with evaluable AVT, 212 had idiopathic/familial PAH (IPAH/FPAH) and 105 had PAH asso

93 polymorphism of human AE3 is associated with idiopathic generalized epilepsy.

94 an AE3 polymorphism A867D is associated with idiopathic generalized epilepsy.

95 Our data point to an idiopathic, genetic, or drug-induced hyperglutamatergic

96 es altered vascular TGF-beta signalling with idiopathic, heritable and autoimmune-associated etiologi

97 h less severe disease, inducible urticarias, idiopathic histaminergic angio-oedema without weals as a

98 sion of secondary causes of eosinophilia, an idiopathic hypereosinophilic syndrome (I-HES) was diagno

99 Idiopathic hypoparathyroidism is a rare endocrine disord

100 Idiopathic hypoparathyroidism is an extremely rare endoc

101 Patients observed due to idiopathic inflammation of the mesentery were identified

102 M) is sometimes used as an umbrella-term for idiopathic inflammatory conditions in the mesentery.

103 Fibrotic idiopathic interstitial pneumonias (fIIP) are a group of

104 e-evaluate the population-based incidence of idiopathic intracranial hypertension (IIH) and to determ

105 retina associated with papilledema owing to idiopathic intracranial hypertension (IIH) at presentati

106 rast-enhanced MR venography in patients with idiopathic intracranial hypertension (IIH).

107 new understanding of the pathophysiology of idiopathic intracranial hypertension and glaucoma.

108 The incidence of idiopathic intracranial hypertension is expected to incr

109 continues to month 12 in participants of the Idiopathic Intracranial Hypertension Treatment Trial (II

110 Investigators of the Idiopathic Intracranial Hypertension Treatment Trial (II

111 tions for various forms of hydrocephalus and idiopathic intracranial hypertension.SIGNIFICANCE STATEM

112 electrophysiological characteristics of the idiopathic intramural LVOT VAs were midrange between tho

113 However, some patients suffer from chronic idiopathic itch that is frequently ascribed to psycholog

114 Idiopathic juxtafoveal retinal telangiectasis type 2 (ma

115 ease was detected in 40% of cases, including idiopathic left ventricular hypertrophy (LVH) and/or fib

116 as definitive therapy for toxic ingestion or idiopathic liver failure (DT) in a level 1 trauma center

117 ing the best electrophysiological measure of idiopathic LVOT VAs was unsuccessful or had to be abando

118 These idiopathic LVOT VAs with a successful anatomic ablation

119 gate the efficacy of an anatomic ablation in idiopathic LVOT VAs.

120 AND We studied 229 consecutive patients with idiopathic LVOT VAs.

121 Idiopathic macular holes (MHs) are a cause of decreased

122 A retrospective study of eyes with idiopathic macular holes that underwent 23-gauge pars pl

123 Children with idiopathic magnetic resonance imaging-classified neonata

124 e immunosuppressive therapy in patients with idiopathic membranous nephropathy and nephrotic syndrome

125 hosphamide (St-Cp) therapy for patients with idiopathic membranous nephropathy at high risk of progre

126 k factors associated with the development of idiopathic MH requiring surgical repair with vitrectomy

127 Development of idiopathic MH requiring surgical repair with vitrectomy.

128 tial new avenues for preventing and treating idiopathic MHs.

129 linical features, treatment, and outcomes of idiopathic multicentric Castleman's disease, which accou

130 been reported only in severe congenital and idiopathic neutropenia patients.

131 Idiopathic NHS was independently associated with lower m

132 Idiopathic noncirrhotic portal hypertension is a heterog

133 Idiopathic normal pressure hydrocephalus (NPH) remains b

134 oward understanding hydrocephalus as well as idiopathic normal pressure hydrocephalus.

135 nefits in patients with initial diagnosis of idiopathic NPH persist in only 32% of patients at 36 mon

136 h retinal/optic nerve disease in 23 (32.4%), idiopathic or congenital motor nystagmus in 22 (31.0%),

137 In total, 95 patients with idiopathic or familial pulmonary arterial hypertension w

138 distinguished well-phenotyped patients with idiopathic or heritable PAH (n=365) from healthy control

139 Eight hundred sixty-four patients with idiopathic or heritable PAH and 16 with pulmonary veno-o

140 n-survivors in 143 consecutive patients with idiopathic or heritable pulmonary arterial hypertension

141 RATIONALE: Idiopathic or heritable pulmonary arterial hypertension

142 onal cohort study, we enrolled patients with idiopathic or heritable pulmonary arterial hypertension

143 re associated with survival in patients with idiopathic or heritable pulmonary arterial hypertension

144 tein panel was validated in 93 patients with idiopathic or heritable pulmonary arterial hypertension

145 ndothelial cells from the same patients with idiopathic or heritable pulmonary arterial hypertension,

146 1% and 12.8% of cases, respectively, whereas idiopathic or undefined forms accounted for 35.7% of cas

147 erial hypertension (PAH) that is hereditary, idiopathic, or associated with other conditions.

148 btypes of IOI: idiopathic dacryoadenitis and idiopathic orbital fat inflammation (2 nonmyositic IOIs)

149 Current practice to diagnose idiopathic orbital inflammation (IOI) is inconsistent, l

150 l fat inflammation (2 nonmyositic IOIs), and idiopathic orbital myositis (myositic IOI).

151 al National Institutes of Health registry on idiopathic PAH (1980-1985).

152 The model was more accurate in patients with idiopathic PAH at 3 years (sensitivity, 89 [95% CI, 65-8

153 Heritable PAH and idiopathic PAH BOECs recapitulated the metabolic abnorma

154 ceptor type 2 (BMPR2) gene and patients with idiopathic PAH to determine mechanisms underlying abnorm

155 d in immune complexes from 16 hereditary and idiopathic PAH versus 12 control lungs.

156 ented increased HMGA1 in PAECs cultured from idiopathic PAH versus donor control lungs.

157 artery endothelial cells from patients with idiopathic PAH, confirming a switch from oxidative phosp

158 literated pulmonary vessels in patients with idiopathic PAH.

159 usive remodeling that characterizes advanced idiopathic PAH.

160 CP attributable to genetic mutation (n = 9), idiopathic pancreatitis (n = 6), idiopathic pancreatitis

161 on (n = 9), idiopathic pancreatitis (n = 6), idiopathic pancreatitis with pancreas divisum (n = 3), a

162 tterns of cardiac sympathetic denervation in idiopathic Parkinson disease (IPD) using (11)C-hydroxyep

163 Idiopathic Parkinson disease is a common neurodegenerati

164 essive neurodegenerative disorder similar to idiopathic Parkinson's disease (IPD).

165 A total of 17 patients with idiopathic Parkinson's disease and 16 age- and sex-match

166 Eligible patients were aged 25-75 years, had idiopathic Parkinson's disease as measured by Queen Squa

167 s of age were identified, including 59% with idiopathic pathogenesis, 32% with familial disease, and

168 oxidised DJ-1 was significantly decreased in idiopathic PD brain, suggesting altered complex function

169 All patients had idiopathic PD with "off" time (time when medication effe

170 ing evidence suggests involvement of DJ-1 in idiopathic PD.

171 disease (PD), and LRRK2 is a risk factor for idiopathic PD.

172 cipants: The Anakinra-Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) double-blind, placebo-

173 en phenotypic similarities between recurrent idiopathic pericarditis and periodic fever syndromes, di

174 100 patients with non-CMV pneumonia, 18 with idiopathic pneumonia syndrome [IPS], and 21 who were asy

175 presence of an allo-LS, which was defined as idiopathic pneumonia syndrome or bronchiolitis obliteran

176 We also evaluated a series of women with idiopathic polyhydramnios who were pregnant with male fe

177 ferent MAGED2 mutations in two families with idiopathic polyhydramnios.

178 absence of inflammation such as in so-called idiopathic (previously 'vasomotor') rhinitis.

179 duration in 376 patients with biopsy-proven idiopathic/primary MGN who achieved a remission after a

180 Idiopathic pulmonary arterial hypertension (IPAH) is usu

181 othelial cells (PAECs) from patients who had idiopathic pulmonary arterial hypertension (PAH) in comp

182 th severe hypoxia-induced PH and humans with idiopathic pulmonary arterial hypertension (PH-Fibs) dis

183 B, MANTIS was downregulated in patients with idiopathic pulmonary arterial hypertension and in rats t

184 irfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis (ASCEND 016; 52 weeks)-for

185 placebo-controlled trials of IFN-gamma-1b in idiopathic pulmonary fibrosis (GIPF-001 [NCT00047645] an

186 h fibrosing ILD, including 456 patients with idiopathic pulmonary fibrosis (IPF) (men, 366; women, 90

187 Cough can be a debilitating symptom of idiopathic pulmonary fibrosis (IPF) and is difficult to

188 ious cause, such as the devastating diseases idiopathic pulmonary fibrosis (IPF) and scleroderma.

189 or the computed tomographic (CT) features of idiopathic pulmonary fibrosis (IPF) and to gain insight

190 ry-related hospitalizations of patients with idiopathic pulmonary fibrosis (IPF) are more frequent th

191 lung injury is related to poor outcome, and idiopathic pulmonary fibrosis (IPF) can be regarded as a

192 urgical lung biopsy, patients diagnosed with idiopathic pulmonary fibrosis (IPF) in clinical practice

193 lcysteine) is used with pirfenidone to treat idiopathic pulmonary fibrosis (IPF) in Europe.

194 RATIONALE: Idiopathic pulmonary fibrosis (IPF) involves the accumul

195 Idiopathic pulmonary fibrosis (IPF) is a chronic age-rel

196 RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a chronic fatal l

197 Idiopathic pulmonary fibrosis (IPF) is a chronic progres

198 Idiopathic pulmonary fibrosis (IPF) is a chronic, progre

199 Idiopathic pulmonary fibrosis (IPF) is a deadly chronic

200 Idiopathic pulmonary fibrosis (IPF) is a devastating dis

201 Idiopathic pulmonary fibrosis (IPF) is a devastating lun

202 Idiopathic pulmonary fibrosis (IPF) is a disease charact

203 Idiopathic pulmonary fibrosis (IPF) is a fatal disease c

204 Idiopathic pulmonary fibrosis (IPF) is a form of progres

205 Idiopathic pulmonary fibrosis (IPF) is a progressive and

206 Idiopathic pulmonary fibrosis (IPF) is a progressive and

207 Idiopathic pulmonary fibrosis (IPF) is a progressive cli

208 Idiopathic pulmonary fibrosis (IPF) is a progressive dis

209 Idiopathic pulmonary fibrosis (IPF) is a progressive par

210 Idiopathic pulmonary fibrosis (IPF) is a progressive, fa

211 RATIONALE: Idiopathic pulmonary fibrosis (IPF) is an increasingly r

212 Idiopathic pulmonary fibrosis (IPF) is progressive and r

213 The clinical course of idiopathic pulmonary fibrosis (IPF) is unpredictable.

214 yofibroblastic differentiation of normal and idiopathic pulmonary fibrosis (IPF) lung fibroblasts.

215 rs, individuals might be diagnosed as having idiopathic pulmonary fibrosis (IPF) or chronic (fibrotic

216 es in the lung microbial community influence idiopathic pulmonary fibrosis (IPF) progression.

217 Idiopathic pulmonary fibrosis (IPF), a chronic and progr

218 ides an updated approach to the diagnosis of idiopathic pulmonary fibrosis (IPF), based on a systemat

219 are effective in slowing the progression of idiopathic pulmonary fibrosis (IPF), it remains a debili

220 expressed in lung tissues from patients with idiopathic pulmonary fibrosis (IPF), whereas PIAS4 prote

221 trol (fibrosis-free) donors or patients with idiopathic pulmonary fibrosis (IPF), which is a very agg

222 tribute to the initiation and progression of idiopathic pulmonary fibrosis (IPF).

223 each been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF).

224 ing and is implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF).

225 e are associated with disease progression in idiopathic pulmonary fibrosis (IPF).

226 agen deposition in fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).

227 plays a crucial role in the pathogenesis of idiopathic pulmonary fibrosis (IPF).

228 y has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF); however, the repert

229 Importantly, in a mouse model of idiopathic pulmonary fibrosis (RAGE-/-), reconstitution

230 l dysfunction and apoptosis are important in idiopathic pulmonary fibrosis and asbestosis.

231 itoring disease progression in patients with idiopathic pulmonary fibrosis and emphysema extent great

232 RATIONALE: Patients with idiopathic pulmonary fibrosis and emphysema may have art

233 dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis disrupt the binding betwee

234 e, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%.

235 Patients with idiopathic pulmonary fibrosis in a clinical trial of pre

236 Idiopathic pulmonary fibrosis is a chronic, progressive

237 Idiopathic pulmonary fibrosis is a devastating lung dise

238 Idiopathic pulmonary fibrosis is a fatal lung disease wi

239 Idiopathic pulmonary fibrosis is a prototype of chronic,

240 Idiopathic pulmonary fibrosis lung alveolar type II cell

241 valuated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.

242 Many patients with suspected idiopathic pulmonary fibrosis present with atypical high

243 -myofibroblast differentiation/activation in idiopathic pulmonary fibrosis remain poorly understood.

244 TH, were higher in lungs from patients with idiopathic pulmonary fibrosis than in control individual

245 ical Markers to Estimate Time-Progression in Idiopathic Pulmonary Fibrosis) study were used to conduc

246 ncological indications and diseases, such as idiopathic pulmonary fibrosis, a number may hold promise

247 ently used to inhibit TGF-beta signalling in idiopathic pulmonary fibrosis, ameliorated BK dysfunctio

248 f two effective treatments for patients with idiopathic pulmonary fibrosis, an accurate diagnosis is

249 ession, in telomere-related diseases such as idiopathic pulmonary fibrosis, as well as in mice and ot

250 Drug Administration (FDA)-approved drug for idiopathic pulmonary fibrosis, for its therapeutic effec

251 pplying the concept of precision medicine to idiopathic pulmonary fibrosis, in particular to search f

252 In clinical trials of idiopathic pulmonary fibrosis, rates of all-cause mortal

253 radiation-induced pulmonary fibrosis and in idiopathic pulmonary fibrosis, two diseases considered t

254 reatment options available for patients with idiopathic pulmonary fibrosis.

255 ated in fibroblasts from human subjects with idiopathic pulmonary fibrosis.

256 was also induced in myofibroblasts in human idiopathic pulmonary fibrosis.

257 dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis.

258 idiopathic cases of organ fibrosis, such as idiopathic pulmonary fibrosis.

259 eir relationship with disease progression in idiopathic pulmonary fibrosis.

260 ease, and interstitial lung diseases such as idiopathic pulmonary fibrosis.

261 as a diagnostic and prognostic biomarker of idiopathic pulmonary fibrosis.

262 cause of the fibrotic changes that underlie idiopathic pulmonary fibrosis.

263 bo-Clinical Studies Assessing Pirfenidone in Idiopathic Pulmonary Fibrosis: Research of Efficacy and

264 -onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between

265 irfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis] trial), including all pat

266 d mortality (0.0237), and treatment-emergent idiopathic-pulmonary-fibrosis-related (0.0132) mortality

267 ent-emergent all-cause mortality (p=0.0420), idiopathic-pulmonary-fibrosis-related mortality (0.0237)

268 0.35 [0.17-0.72; 0.0029]; treatment-emergent idiopathic-pulmonary-fibrosis-related mortality 0.32 [0.

269 ll-cause mortality 0.45 [0.24-0.83; 0.0094]; idiopathic-pulmonary-fibrosis-related mortality 0.35 [0.

270 is-related mortality, and treatment-emergent idiopathic-pulmonary-fibrosis-related mortality at weeks

271 ity, treatment-emergent all-cause mortality, idiopathic-pulmonary-fibrosis-related mortality, and tre

272 pamine transporter (DAT) imaging to identify idiopathic rapid eye movement sleep behavior disorder (I

273 Idiopathic retroperitoneal fibrosis (RPF), reviewed here

274 symptoms of presumed cardiac involvement of idiopathic retroperitoneal fibrosis, otherwise known as

275 tion of capsaicin treatment in patients with idiopathic rhinitis (IR) is based on ablation of the tra

276 the efficacy of capsaicin nasal treatment in idiopathic rhinitis (IR).

277 m healthy control subjects, AR patients, and idiopathic rhinitis patients and were tested in vitro.

278 ne as well as nasal secretions of AR but not idiopathic rhinitis patients rapidly decreased epithelia

279 Idiopathic scoliosis (IS) is a complex pediatric disease

280 Adolescent idiopathic scoliosis is a complex disease with unclear e

281 re approximately equally distributed between idiopathic, secondary, and hemorrhagic transformation.

282 den the phenotypic spectrum in patients with idiopathic short stature we performed sequence analyses

283 f the cartilage matrix, were associated with idiopathic short stature.

284 ommon cause of isolated as well as inherited idiopathic short stature.

285 ug approved for use in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) who remain sy

286 reover, exome sequencing of individuals with idiopathic SZ identified a rare missense mutation in DGC

287 METHODS AND We studied 14 patients with idiopathic VA origins in the parietal band among 294 con

288 whereas it was unlikely to be successful for idiopathic VAs originating from the basal left ventricul

289 anatomic ablation was highly successful for idiopathic VAs originating from the intramural LVOT (>75

290 Idiopathic VAs rarely originated from the parietal band.

291 However, the burden of idiopathic ventricular arrhythmias (IVA) in the general

292 Idiopathic ventricular arrhythmias (VAs) originating fro

293 ical characteristics and ablation outcome of idiopathic ventricular arrhythmias (VAs) originating fro

294 preclude radiofrequency catheter ablation of idiopathic ventricular arrhythmias (VAs) originating fro

295 .Pro955fsX95, PKP2-p.Arg79X, and the Chr7q36 idiopathic ventricular fibrillation risk haplotype) in a

296 Although the rate of idiopathic ventricular tachycardia is similar across sex

297 Of these, 177 (28.8%) had idiopathic ventricular tachycardia, 408 (66.5%) had symp

298 In idiopathic ventricular tachycardia, there was an increas

299 nesthesia from a young boy with a history of idiopathic vitreous hemorrhage and a female infant with

300 al trait corresponding with both genetic and idiopathic vulnerability for high MA preference and taki